SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Bob Swift who wrote (3307)6/17/1999 10:52:00 AM
From: M. Ramle  Respond to of 10280
 
Bob:

My take on the 25K buy order is that when the client confirmed the order with the MM, there wasn't enough shares in his inventory to meet that Buy-order. By the same token, the MM could not take the price down to shake the weak hands because it looked like there was consistent buying right from the opening. So for once (and I hope it is only the beginning), the MM was forced to go into the open market and buy the shares to meet that Buy-order.

So far so good. It is very important to close above $69 1/2 which has been the overhead resistance. The next resistance is sitting right around the $82 range, which is the more critical one. Good Luck.

Mazen



To: Bob Swift who wrote (3307)6/17/1999 11:22:00 AM
From: David Howe  Read Replies (3) | Respond to of 10280
 
No suckers. Pretty good price if you ask me.

The Goldman Saks conference may be contributing to the recent strength. There was a rumor that GS might be initiating coverage of Sepracor in the near future. I think it is likely and that it will be the news that moves SEPR back above the 200 day moving average and into the 80s.

Just a guess.

Dave


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News